A Systematic Pan-Cancer Analysis of YY1 Aberrations and their Relationship with Clinical Outcome, Tumor Microenvironment, and Therapeutic Targets

Figure 7

Phosphorylation of the YY1 protein in various tumors. We used UALCAN to compare the expression levels of YY1 phosphorylated proteins (NP_003394.1, S118, and S247 sites) among chosen normal tissue and primary tissue using the CPTAC. The phosphoprotein locations that yielded positive findings are depicted in the YY1 protein’s schematic design (a). We provide the box plots for various malignancies such as breast cancer (b), ovarian cancer (c), colon cancer (d), clear cell RCC (e), UCEC (f), and LUAD (g).

(a)

(b)

(c)

(d)

(e)

(f)

(g)